GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE3) » Definitions » Ending Cash Position

Qiagen NV (WBO:QGE3) Ending Cash Position : €634 Mil (As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Qiagen NV Ending Cash Position?

Qiagen NV's Ending Cash Position for the quarter that ended in Dec. 2024 was €634 Mil.

Qiagen NV's quarterly Ending Cash Position increased from Jun. 2024 (€496 Mil) to Sep. 2024 (€877 Mil) but then declined from Sep. 2024 (€877 Mil) to Dec. 2024 (€634 Mil).

Qiagen NV's annual Ending Cash Position declined from Dec. 2022 (€690 Mil) to Dec. 2023 (€613 Mil) but then increased from Dec. 2023 (€613 Mil) to Dec. 2024 (€634 Mil).

Qiagen NV Ending Cash Position Historical Data

The historical data trend for Qiagen NV's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qiagen NV Ending Cash Position Chart

Qiagen NV Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 491.54 779.26 689.75 612.63 633.70

Qiagen NV Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 612.63 472.58 495.76 876.66 633.70

Qiagen NV Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Qiagen NV's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=638.021+-4.326
=634

Qiagen NV's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=929.201+-295.506
=634

Qiagen NV Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Qiagen NV's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Qiagen NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Qiagen NV (WBO:QGE3) » Definitions » Ending Cash Position
Comparable Companies
MEDP EXAS RVTY ICLR GH ILMN CRL RDNT WGS SHC TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD NTRA WAT
Traded in Other Exchanges
QGEN:USA 1QGEN:Italy QIAd:UK 0RLT:UK QIA:Germany QIA:Germany QIA:Germany
Address
Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Website
https://www.qiagen.com
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).

Qiagen NV Headlines

No Headlines